Interferon Therapy for Bronchial Papillomatosis Controlled by Papillomavirus-DNA Hybridization
- 1 February 1985
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA Otolaryngology–Head & Neck Surgery
- Vol. 111 (2) , 96-98
- https://doi.org/10.1001/archotol.1985.00800040060007
Abstract
• In biopsy specimens from a patient with tracheal and bronchial papillomatosis, human papillomavirus (HPV) type 11 DNA was identified. Treatment with leukocyte interferon was initiated, and the results of therapy was monitored by molecular hybridization of biopsy specimens with phosphorus 32-labeled HPV type 11 DNA after interferon application. There was no improvement of the clinical course, although two of five biopsy specimens showed a considerable reduction in the amount of HPV type 11. We discuss the reasons for the insufficient effect of therapy and propose molecular hybridization as an additional method for therapy control in viral diseases. (Arch Otolaryngol 1985;111:96-98)This publication has 6 references indexed in Scilit:
- Laryngeal Papillomavirus Infection during Clinical RemissionNew England Journal of Medicine, 1983
- Molecular cloning and characterization of human papilloma virus DNA derived from a laryngeal papillomaJournal of Virology, 1982
- Analysis of human genital warts (condylomata acuminata) and other genital tumors for human papillomavirus type 6 DNAInternational Journal of Cancer, 1982
- Interferon Therapy in Juvenile Laryngeal PapillomatosisJAMA Otolaryngology–Head & Neck Surgery, 1981
- [9] Procedures for large-scale production and partial purification of human interferon from lymphocyte (Namalva) culturesPublished by Elsevier ,1981
- Human Leukocyte Interferon for the Treatment of Herpes Zoster in Patients with CancerNew England Journal of Medicine, 1978